Tag

nsclc

Carbon ion radiotherapy yielded 82.9% two-year locoregional control in stage III non-small cell lung cancer

Carbon ion radiotherapy achieved 82.9% two-year locoregional control, while combined immunotherapy was associated with longer overall survival.

Longer pembrolizumab exposure after chemoradiation was associated with lower mortality, but immortal time bias prevents causal interpretation.